Supplements and Featured Publications
Understanding the Diagnosis, Management, and Treatment Options for Neurogenic Orthostatic Hypoten
Volume: 21
Issue: 13
Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Chal
Volume: 21
Issue: 12 Suppl
Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin
Volume: 21
Issue: 11 Suppl
Use of Opioid Analgesics in Managed Care Practice: Challenges, Controversies, REMS, and Optimizing P
Volume: 21
Issue: 9 Suppl
Parkinson’s Disease Psychosis: Symptoms, Management, and Economic Burden
Volume: 21
Issue: 10 Suppl
The Evolving Treatment Landscape and Innovative Payment Models in Oncology: An Expert Summit
Reductions in Mortality Among Medicare Beneficiaries Following the Implementation of Medicare Part D
Volume: 21
Issue: 9 Suppl
Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?
Volume: 21
Issue: 8 Suppl
ADA 2015 Conference Coverage
![Special Issue: Product Pipeline Review [June]](https://cdn.sanity.io/images/0vv8moc6/ajmc/eeaf31968f6213cadba3d4100dae372938facbce-3347x4569.png?w=230&fit=crop&auto=format)
Special Issue: Product Pipeline Review [June]
Volume: 21
The Evidence Behind the Evidence: A Deeper Dive Into the Management of Chronic Heart Failure
Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection
Volume: 21
Issue: 7 Suppl
![Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/05019000301109976bb5bd6b274a4f5482f94f89-900x1229.jpg?w=230&fit=crop&auto=format)
Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]
Volume: 21
Issue: 6 Suppl
Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations [CME
Volume: 21
Issue: 5 Suppl
Economic Evaluation of a Fluocinolone Acetonide Intravitreal Implant for Patients With DME Based on
Volume: 21
Issue: 4 Suppl
Characterizing Pulmonary Hypertension–Related Hospitalization Costs Among Medicare Advantage or Co
Volume: 21
Issue: 3 Suppl
Standards of Care Issues With Anticoagulation in Real-World Populations
Volume: 21
Issue: 2 Suppl
![Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/371bb77085a8399820783447221ceeedad255a69-900x1229.jpg?w=230&fit=crop&auto=format)
Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]
Volume: 21
Issue: 1 Suppl
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Volume: 20
Issue: 14 Suppl
Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Anal
Volume: 20
Issue: 13 Suppl
![Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/69d5242675a80905871256fe7bfe3ffa65a48be6-2363x3226.jpg?w=230&fit=crop&auto=format)
Prostate Cancer Management: Enhancing Cost-Effectiveness and Patient Outcomes [CME/CPE]
Volume: 20
Issue: 12 Suppl
Implications for Multiple Sclerosis in the Era of the Affordable Care Act: A Clinical and Managed Ca
Volume: 20
Issue: 11 Suppl
Evidence-Based Cardiology - December
Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era
Volume: 20
Issue: 9 Suppl
Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus
Volume: 20
Issue: 10 Suppl
Evidence-Based Cardiology - October
ADA 2014 Conference Coverage
Balancing Therapeutic Safety and Efficacy to Improve Clinical and Economic Outcomes in Schizophrenia
Volume: 20
Issue: 8 Suppl
Improving Clinical and Managed Care Outcomes in Rheumatoid Arthritis: New Guidelines, Therapies, and
Volume: 20
Issue: 7 Suppl
Clinical Trial Designs in PAH: Shifting From Functional Measurements to Long-term Clinical Outco
Volume: 20
Issue: 6 Suppl
Advertisement
Advertisement
Trending on AJMC
1
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
2
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera
5